Sugi Predict

Sugi Predict / Compounds / SCHEMBL9605855

SCHEMBL9605855

SCHEMBL9605855

CCOC(=O)[C@H]1[C@H](C(=O)OCC)[C@H]2C=C[C@@H]1C2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.57
▸ ALDH1A1 P00352 6/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ LMNA P02545 1/20 0.45
▸ PPM1B O75688 1/20 0.44
▸ PTPN1 P18031 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PPP1CC P36873 1/20 0.44
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CASP6 P55212 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19318635 1.00 POLB (0.57) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL10050523 1.00 POLB (0.57) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL1451358 1.00 POLB (0.57) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL5837756 0.93 POLB (0.69) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL5837751 0.93 POLB (0.69) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL19318937 0.93 POLB (0.51) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL19318637 0.93 POLB (0.69) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL19318634 0.93 POLB (0.69) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL7594331 0.93 POLB (0.69) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL19324112 0.93 POLB (0.69) POLBALDH1A1SMN1; SMN2HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890244-B2 Thermally decomposable polymer compositions incorporating thermally activated base generators SUMITOMO BAKELITE CO., LTD. (JP) 2018-02-13 — — US disclosed
US-9765200-B2 Polymer composition for microelectronic assembly PROMERUS, LLC (US) 2017-09-19 — — US disclosed
US-9765200-B2 Polymer composition for microelectronic assembly PROMERUS, LLC (US) 2017-09-19 — — US disclosed
US-9757818-B2 Thermally decomposable polymer compositions for forming microelectronic assemblies PROMERUS, LLC (US) 2017-09-12 — — US disclosed
US-9757818-B2 Thermally decomposable polymer compositions for forming microelectronic assemblies PROMERUS, LLC (US) 2017-09-12 — — US disclosed
US-20170253614-A1 HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-09-07 — — US disclosed
US-20170253614-A1 HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-09-07 — — US disclosed
US-20170036308-A1 THERMALLY DECOMPOSABLE POLYMER COMPOSITIONS FOR FORMING MICROELECTRONIC ASSEMBLIES PROMERUS, LLC (US) 2017-02-09 — — US disclosed
US-20170036308-A1 THERMALLY DECOMPOSABLE POLYMER COMPOSITIONS FOR FORMING MICROELECTRONIC ASSEMBLIES PROMERUS, LLC (US) 2017-02-09 — — US disclosed
US-9505948-B2 Thermally decomposable polymer compositions for forming microelectronic assemblies PROMERUS, LLC (US) 2016-11-29 — — US disclosed
US-9115300-B2 Thermally decomposable polymer compositions incorporating thermally activated base generators PROMERUS, LLC 2015-08-25 — — US disclosed
WO-2014099614-A1 THERMALLY DECOMPOSABLE POLYMER COMPOSITION FOR FORMING MICROELECTRIC ASSEMBLIES PROMERUS, LLC (US) 2014-06-26 — — WO disclosed
US-8729215-B2 Sacrificial polymer compositions including polycarbonates having repeat units derived from stereospecific polycyclic 2,3-diol monomers PROMERUS, LLC (US) 2014-05-20 — — US disclosed
US-20140024799-A1 Sacrificial Polymer Compositions Including Polycarbonates Having Repeat Units Derived From Stereospecific Polycyclic 2,3-Diol Monomers PROMERUS, LLC (US) 2014-01-23 — — US disclosed
US-8575297-B2 Sacrificial polymer compositions including polycarbonates having repeat units derived from stereospecific polycyclic 2,3-diol monomers Promerus, LCC (US) 2013-11-05 — — US disclosed
US-8535454-B2 Polymer composition for microelectronic assembly PROMERUS, LLC (US) 2013-09-17 — — US disclosed
US-20120318854-A1 THERMALLY DECOMPOSABLE POLYMER COMPOSITIONS INCORPORATING THERMALLY ACTIVATED BASE GENERATORS PROMERUS LLC (US) 2012-12-20 — — US disclosed
US-20120298729-A1 Polymer Composition for Microelectronic Assembly PROMERUS LLC (US) 2012-11-29 — — US disclosed
WO-2012071319-A2 POLYMER COMPOSITION FOR MICROELECTRONIC ASSEMBLY PROMERUS LLC (US) 2012-05-31 — — WO disclosed
US-20120031556-A1 Sacrificial Polymer Compositions Including Polycarbonates Having Repeat Units Derived from Stereospecific Polycyclic 2,3-Diol Monomers PROMERUS LLC (US) 2012-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170253614-A1 HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS HAVCR2, HCCS, LIPC POLB 2951/4885ALDH1A1 1148/4885SMN1; SMN2 4871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.